Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
330 participants
INTERVENTIONAL
2007-09-30
2010-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
SBA includes the administration of scripted, brief cessation counseling that follows standard health care smoking cessation guidelines. The counseling covers the 5As and 5Rs. The 5As are: Ask about smoking or tobacco use, Advise all smokers to stop smoking, Assess willingness to quit, Assist with cessation, and Arrange for follow-up). The 5 R's are used by clinicians to help motivate participants who are not yet ready to change to quit smoking; they are Relevance - emphasize the benefits of quitting, Risks - inform the participant of the risks of continuing in smoking, Rewards - emphasize the benefits of quitting, Road Blocks - identify barriers to cessation, and, finally, Repetition or repeating the other four R's at every encounter.
Participants in both groups will receive 5 counseling sessions over 8 weeks with the respective intervention. Participants randomized to the MI condition will receive five 45-60 minute MI sessions over the course of 8 weeks; 3 sessions occur in the office and the last 2 can be either by telephone or in the office. Participants randomized to the SBA condition will receive five 15-30 minute didactic SBA sessions over the course of 8 weeks; 3 sessions occur in the office and the last 2 can be either by telephone or in the office. Research staff will offer participants in both groups smoking reduction and cessation materials including websites, printed materials, hotlines, referrals to smoking cessation counseling programs. Participants will complete follow-up assessments at 8, 12 and 24 weeks post baseline. Self-reported smoking cessation, recorded on timeline followback calendars, will be biochemically verified via saliva cotinine tests at follow-up assessment visits. Prior to enrolling participants for randomization, each MI counselor will be certified for competence by completing the full, manualized treatment with up to 10 pilot participants.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Motivational Interviewing (MI)
Motivational Interviewing (MI)
MI is an empirically supported, client-centered, directive method for matching counseling to an individual's readiness to change.
2
Structured Brief Advice (SBA)
Structured Brief Advice (SBA)
SBA includes the administration of scripted, brief cessation counseling that follows standard health care smoking cessation guidelines.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motivational Interviewing (MI)
MI is an empirically supported, client-centered, directive method for matching counseling to an individual's readiness to change.
Structured Brief Advice (SBA)
SBA includes the administration of scripted, brief cessation counseling that follows standard health care smoking cessation guidelines.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Must have smoked at least one cigarette during the past 30 days.
3. Must have smoked at least 100 cigarettes in their lifetime.
4. Fluent in English
5. Signed and dated IRB approved informed consent form (and assent form for subjects of appropriate age as required by each institution)
Exclusion Criteria
2. Currently incarcerated or in a court mandated facility.
14 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital of Philadelphia
OTHER
University of Pittsburgh
OTHER
Lehigh Valley Hospital
OTHER
Pennsylvania Department of Health
OTHER_GOV
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Janet Audrain-McGovern, Ph.D
Role: STUDY_CHAIR
University of Pennsylvania
Deborah Moss, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh
Sarah Stevens, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Lehigh Valley Hospital
Jon Pletcher, MD
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh
Pamela Murray, MD, MHP
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh
Sara B Kinsman, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
The Children's Hospital of Philadelphia/University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lehigh Valley Hospital
Allentown, Pennsylvania, United States
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kalkhuis-Beam S, Stevens SL, Baumritter A, Carlson EC, Pletcher JR, Rodriguez D, Audrain-McGovern J. Participant- and study-related characteristics predicting treatment completion and study retention in an adolescent smoking cessation trial. J Adolesc Health. 2011 Oct;49(4):371-8. doi: 10.1016/j.jadohealth.2011.01.012. Epub 2011 May 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SAP#4100027295_2
Identifier Type: -
Identifier Source: org_study_id